Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Metformin for non-obese Type II Diabetes

Previously, this site has advised the use of metformin as a first line therapy in all patients with type II diabetes.

This advice was based upon the reductions in risk of myocardial infarction seen in obese patients taking metformin in UKPDS1 however some recommendations suggest that sulphonylureas should be used in type II diabetics who are not obese.

A study in Diabetes Care has compared metformin therapy in normal, overweight and obese individuals. The abstract concludes that "metformin is at least as efficacious in normal and overweight individuals as it is in those who are obese" after the results demonstrated that HbA1c was not different in the three groups and that there were no statistically significant differences in diabetes-related complications.

Action: This study provides evidential support for metformin use in non-obese individuals with type II diabetes. Metformin is the first line agent for all patients with type II diabetes.

References

  1. United Kingdom Prospective Diabetes Study

Share 'Metformin for non-obese Type II Diabetes' on Email Share 'Metformin for non-obese Type II Diabetes' on Delicious Share 'Metformin for non-obese Type II Diabetes' on Digg Share 'Metformin for non-obese Type II Diabetes' on Facebook Share 'Metformin for non-obese Type II Diabetes' on Google+ Share 'Metformin for non-obese Type II Diabetes' on reddit Share 'Metformin for non-obese Type II Diabetes' on StumbleUpon Share 'Metformin for non-obese Type II Diabetes' on Twitter

atomic-wealth

No Comments to “Metformin for non-obese Type II Diabetes”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,527 spam comments.

atomic-wealth
fond-illness
summer